Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q20707932> ?p ?o }
Showing triples 1 to 46 of
46
with 100 triples per page.
- Q20707932 subject Q20740287.
- Q20707932 subject Q7335370.
- Q20707932 subject Q7441579.
- Q20707932 subject Q7579524.
- Q20707932 subject Q8955377.
- Q20707932 subject Q9062056.
- Q20707932 abstract "Basmisanil (INN) (developmental code names RG-1662, RO5186582) is a highly selective inverse agonist/negative allosteric modulator of α5 subunit-containing GABAA receptors which is under development by Roche for the treatment of cognitive impairment associated with Down syndrome. As of August 2015, it is in phase II clinical trials for this indication.".
- Q20707932 atcPrefix "None".
- Q20707932 casNumber "1159600-41-5".
- Q20707932 iupacName "(1,1-Dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone".
- Q20707932 pubchem "57336276".
- Q20707932 thumbnail Basmisanil.svg?width=300.
- Q20707932 wikiPageExternalLink 800031595.
- Q20707932 wikiPageWikiLink Q15410190.
- Q20707932 wikiPageWikiLink Q1671731.
- Q20707932 wikiPageWikiLink Q18025082.
- Q20707932 wikiPageWikiLink Q20740287.
- Q20707932 wikiPageWikiLink Q212646.
- Q20707932 wikiPageWikiLink Q2649417.
- Q20707932 wikiPageWikiLink Q30612.
- Q20707932 wikiPageWikiLink Q47715.
- Q20707932 wikiPageWikiLink Q5141203.
- Q20707932 wikiPageWikiLink Q60147.
- Q20707932 wikiPageWikiLink Q6456072.
- Q20707932 wikiPageWikiLink Q7121197.
- Q20707932 wikiPageWikiLink Q7180990.
- Q20707932 wikiPageWikiLink Q7335370.
- Q20707932 wikiPageWikiLink Q7441579.
- Q20707932 wikiPageWikiLink Q7579524.
- Q20707932 wikiPageWikiLink Q7669463.
- Q20707932 wikiPageWikiLink Q8083967.
- Q20707932 wikiPageWikiLink Q824258.
- Q20707932 wikiPageWikiLink Q8955377.
- Q20707932 wikiPageWikiLink Q9062056.
- Q20707932 atcPrefix "None".
- Q20707932 casNumber "1159600".
- Q20707932 iupacName "-[6-[[3--5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone".
- Q20707932 pubchem "57336276".
- Q20707932 type ChemicalSubstance.
- Q20707932 type Drug.
- Q20707932 type ChemicalObject.
- Q20707932 type Thing.
- Q20707932 type Q8386.
- Q20707932 comment "Basmisanil (INN) (developmental code names RG-1662, RO5186582) is a highly selective inverse agonist/negative allosteric modulator of α5 subunit-containing GABAA receptors which is under development by Roche for the treatment of cognitive impairment associated with Down syndrome. As of August 2015, it is in phase II clinical trials for this indication.".
- Q20707932 label "Basmisanil".
- Q20707932 depiction Basmisanil.svg.